This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
5laq
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==Crystal structure of human phosphodiesterase 4B catalytic domain with inhibitor NPD-001== | |
| - | + | <StructureSection load='5laq' size='340' side='right' caption='[[5laq]], [[Resolution|resolution]] 2.40Å' scene=''> | |
| - | + | == Structural highlights == | |
| - | + | <table><tr><td colspan='2'>[[5laq]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5LAQ OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5LAQ FirstGlance]. <br> | |
| - | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=6M5:(4~{a}~{S},8~{a}~{R})-2-cycloheptyl-4-[4-methoxy-3-[4-[4-(1~{H}-1,2,3,4-tetrazol-5-yl)phenoxy]butoxy]phenyl]-4~{a},5,8,8~{a}-tetrahydrophthalazin-1-one'>6M5</scene>, <scene name='pdbligand=ACT:ACETATE+ION'>ACT</scene>, <scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr> | |
| - | [[ | + | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[5g57|5g57]], [[5g2b|5g2b]], [[5l8c|5l8c]], [[5l9h|5l9h]], [[5g5v|5g5v]], [[5l8y|5l8y]]</td></tr> |
| - | [[Category: Brown, D | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5laq FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5laq OCA], [http://pdbe.org/5laq PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5laq RCSB], [http://www.ebi.ac.uk/pdbsum/5laq PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5laq ProSAT]</span></td></tr> |
| - | [[Category: Singh, A | + | </table> |
| + | == Function == | ||
| + | [[http://www.uniprot.org/uniprot/PDE4B_HUMAN PDE4B_HUMAN]] Hydrolyzes the second messenger cAMP, which is a key regulator of many important physiological processes. May be involved in mediating central nervous system effects of therapeutic agents ranging from antidepressants to antiasthmatic and anti-inflammatory agents.<ref>PMID:10846163</ref> <ref>PMID:15003452</ref> | ||
| + | == References == | ||
| + | <references/> | ||
| + | __TOC__ | ||
| + | </StructureSection> | ||
| + | [[Category: Brown, D G]] | ||
| + | [[Category: Singh, A K]] | ||
| + | [[Category: Alternative splicing]] | ||
| + | [[Category: Camp]] | ||
| + | [[Category: Hydrolase]] | ||
| + | [[Category: Phosphodiesterase]] | ||
Revision as of 06:17, 14 March 2018
Crystal structure of human phosphodiesterase 4B catalytic domain with inhibitor NPD-001
| |||||||||||
